Brief: Calidi Biotherapeutics Announces Pricing Of $2 Mln Registered Direct Offering And Concurrent Private Placement
23/10/2024 13:41
Oct 23 (Reuters) - Calidi Biotherapeutics Inc CLDI.A :
* CALIDI BIOTHERAPEUTICS ANNOUNCES PRICING OF $2 MILLION
REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT
Source text for Eikon: ID:nGNX4MMpkx
Further company coverage: CLDI.A
((Reuters.Briefs@thomsonreuters.com))
Recent news on Calidi Biotherapeutics
See all newsBrief: Calidi Biotherapeutics Announces Strategic Partnership With Transferai
Brief: Calidi Biotherapeutics Announces Partnership With Avance Clinical To Facilitate Australian Regulatory Approval
Brief: Calidi Biotherapeutics Announces Pricing Of $5.2 Million Underwritten Public Offering
Brief: Calidi Biotherapeutics Eliminates Chief Legal Officer Position - SEC Filing
Brief: Calidi Biotherapeutics Receives FDA Fast Track Designation For Cld-201 (Supernova), A First-In-Class Stem-Cell Loaded Viral Therapy For The Treatment Of Patients With Soft Tissue Sarcoma